The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Marijuana (MMJ) Market Research Report 2025
Synopsis
The global Pharmaceutical Marijuana (MMJ) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Marijuana (MMJ), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Marijuana (MMJ).
Report Scope
The Pharmaceutical Marijuana (MMJ) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Marijuana (MMJ) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Marijuana (MMJ) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Canopy Growth Corporation
GW Pharmaceuticals, plc
Aurora Cannabis, Inc.
Aphria, Inc.
MedReleaf Corporation
Insys Therapeutics, Inc.
CanniMed Therapeutics, Inc.
Cara Therapeutics, Inc.
United Cannabis Corporation
Segment by Type
THC-dominant
CBD-dominant
Balanced THC & CBD
Segment by Application
Cancer
Arthritis
Migraine
Epilepsy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Marijuana (MMJ) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Marijuana (MMJ) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pharmaceutical Marijuana (MMJ) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Marijuana (MMJ), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Marijuana (MMJ).
Report Scope
The Pharmaceutical Marijuana (MMJ) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Marijuana (MMJ) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Marijuana (MMJ) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Canopy Growth Corporation
GW Pharmaceuticals, plc
Aurora Cannabis, Inc.
Aphria, Inc.
MedReleaf Corporation
Insys Therapeutics, Inc.
CanniMed Therapeutics, Inc.
Cara Therapeutics, Inc.
United Cannabis Corporation
Segment by Type
THC-dominant
CBD-dominant
Balanced THC & CBD
Segment by Application
Cancer
Arthritis
Migraine
Epilepsy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Marijuana (MMJ) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Marijuana (MMJ) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pharmaceutical Marijuana (MMJ) Market Overview
1.1 Product Overview and Scope of Pharmaceutical Marijuana (MMJ)
1.2 Pharmaceutical Marijuana (MMJ) Segment by Type
1.2.1 Global Pharmaceutical Marijuana (MMJ) Market Value Comparison by Type (2024-2030)
1.2.2 THC-dominant
1.2.3 CBD-dominant
1.2.4 Balanced THC & CBD
1.3 Pharmaceutical Marijuana (MMJ) Segment by Application
1.3.1 Global Pharmaceutical Marijuana (MMJ) Market Value by Application: (2024-2030)
1.3.2 Cancer
1.3.3 Arthritis
1.3.4 Migraine
1.3.5 Epilepsy
1.3.6 Others
1.4 Global Pharmaceutical Marijuana (MMJ) Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Marijuana (MMJ) Revenue 2019-2030
1.4.2 Global Pharmaceutical Marijuana (MMJ) Sales 2019-2030
1.4.3 Global Pharmaceutical Marijuana (MMJ) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharmaceutical Marijuana (MMJ) Market Competition by Manufacturers
2.1 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pharmaceutical Marijuana (MMJ) Average Price by Manufacturers (2019-2024)
2.4 Global Pharmaceutical Marijuana (MMJ) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Product Type & Application
2.7 Pharmaceutical Marijuana (MMJ) Market Competitive Situation and Trends
2.7.1 Pharmaceutical Marijuana (MMJ) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Marijuana (MMJ) Players Market Share by Revenue
2.7.3 Global Pharmaceutical Marijuana (MMJ) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Marijuana (MMJ) Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Marijuana (MMJ) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharmaceutical Marijuana (MMJ) Global Pharmaceutical Marijuana (MMJ) Sales by Region: 2019-2030
3.2.1 Global Pharmaceutical Marijuana (MMJ) Sales by Region: 2019-2024
3.2.2 Global Pharmaceutical Marijuana (MMJ) Sales by Region: 2025-2030
3.3 Global Pharmaceutical Marijuana (MMJ) Global Pharmaceutical Marijuana (MMJ) Revenue by Region: 2019-2030
3.3.1 Global Pharmaceutical Marijuana (MMJ) Revenue by Region: 2019-2024
3.3.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Region: 2025-2030
3.4 North America Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Marijuana (MMJ) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2030)
3.4.3 North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Marijuana (MMJ) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2030)
3.5.3 Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Marijuana (MMJ) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Marijuana (MMJ) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2030)
3.7.3 Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Marijuana (MMJ) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Marijuana (MMJ) Sales by Type (2019-2030)
4.1.1 Global Pharmaceutical Marijuana (MMJ) Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Marijuana (MMJ) Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2019-2030)
4.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Type (2019-2030)
4.2.1 Global Pharmaceutical Marijuana (MMJ) Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2019-2030)
4.3 Global Pharmaceutical Marijuana (MMJ) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharmaceutical Marijuana (MMJ) Sales by Application (2019-2030)
5.1.1 Global Pharmaceutical Marijuana (MMJ) Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Marijuana (MMJ) Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2019-2030)
5.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Application (2019-2030)
5.2.1 Global Pharmaceutical Marijuana (MMJ) Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2019-2030)
5.3 Global Pharmaceutical Marijuana (MMJ) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Canopy Growth Corporation
6.1.1 Canopy Growth Corporation Corporation Information
6.1.2 Canopy Growth Corporation Description and Business Overview
6.1.3 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product Portfolio
6.1.5 Canopy Growth Corporation Recent Developments/Updates
6.2 GW Pharmaceuticals, plc
6.2.1 GW Pharmaceuticals, plc Corporation Information
6.2.2 GW Pharmaceuticals, plc Description and Business Overview
6.2.3 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product Portfolio
6.2.5 GW Pharmaceuticals, plc Recent Developments/Updates
6.3 Aurora Cannabis, Inc.
6.3.1 Aurora Cannabis, Inc. Corporation Information
6.3.2 Aurora Cannabis, Inc. Description and Business Overview
6.3.3 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
6.3.5 Aurora Cannabis, Inc. Recent Developments/Updates
6.4 Aphria, Inc.
6.4.1 Aphria, Inc. Corporation Information
6.4.2 Aphria, Inc. Description and Business Overview
6.4.3 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
6.4.5 Aphria, Inc. Recent Developments/Updates
6.5 MedReleaf Corporation
6.5.1 MedReleaf Corporation Corporation Information
6.5.2 MedReleaf Corporation Description and Business Overview
6.5.3 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product Portfolio
6.5.5 MedReleaf Corporation Recent Developments/Updates
6.6 Insys Therapeutics, Inc.
6.6.1 Insys Therapeutics, Inc. Corporation Information
6.6.2 Insys Therapeutics, Inc. Description and Business Overview
6.6.3 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
6.6.5 Insys Therapeutics, Inc. Recent Developments/Updates
6.7 CanniMed Therapeutics, Inc.
6.6.1 CanniMed Therapeutics, Inc. Corporation Information
6.6.2 CanniMed Therapeutics, Inc. Description and Business Overview
6.6.3 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
6.7.5 CanniMed Therapeutics, Inc. Recent Developments/Updates
6.8 Cara Therapeutics, Inc.
6.8.1 Cara Therapeutics, Inc. Corporation Information
6.8.2 Cara Therapeutics, Inc. Description and Business Overview
6.8.3 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
6.8.5 Cara Therapeutics, Inc. Recent Developments/Updates
6.9 United Cannabis Corporation
6.9.1 United Cannabis Corporation Corporation Information
6.9.2 United Cannabis Corporation Description and Business Overview
6.9.3 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product Portfolio
6.9.5 United Cannabis Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Marijuana (MMJ) Industry Chain Analysis
7.2 Pharmaceutical Marijuana (MMJ) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Marijuana (MMJ) Production Mode & Process
7.4 Pharmaceutical Marijuana (MMJ) Sales and Marketing
7.4.1 Pharmaceutical Marijuana (MMJ) Sales Channels
7.4.2 Pharmaceutical Marijuana (MMJ) Distributors
7.5 Pharmaceutical Marijuana (MMJ) Customers
8 Pharmaceutical Marijuana (MMJ) Market Dynamics
8.1 Pharmaceutical Marijuana (MMJ) Industry Trends
8.2 Pharmaceutical Marijuana (MMJ) Market Drivers
8.3 Pharmaceutical Marijuana (MMJ) Market Challenges
8.4 Pharmaceutical Marijuana (MMJ) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pharmaceutical Marijuana (MMJ) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pharmaceutical Marijuana (MMJ) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pharmaceutical Marijuana (MMJ) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) of Key Manufacturers (2019-2024)
Table 5. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pharmaceutical Marijuana (MMJ) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pharmaceutical Marijuana (MMJ) Average Price (US$/KG) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pharmaceutical Marijuana (MMJ), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Product Type & Application
Table 12. Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical Marijuana (MMJ) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Marijuana (MMJ) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Marijuana (MMJ) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pharmaceutical Marijuana (MMJ) Sales by Region (2019-2024) & (Kiloton)
Table 18. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2019-2024)
Table 19. Global Pharmaceutical Marijuana (MMJ) Sales by Region (2025-2030) & (Kiloton)
Table 20. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2025-2030)
Table 21. Global Pharmaceutical Marijuana (MMJ) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2019-2024)
Table 23. Global Pharmaceutical Marijuana (MMJ) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2025-2030)
Table 25. North America Pharmaceutical Marijuana (MMJ) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2024) & (Kiloton)
Table 27. North America Pharmaceutical Marijuana (MMJ) Sales by Country (2025-2030) & (Kiloton)
Table 28. North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2024) & (Kiloton)
Table 32. Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2025-2030) & (Kiloton)
Table 33. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pharmaceutical Marijuana (MMJ) Sales by Region (2019-2024) & (Kiloton)
Table 37. Asia Pacific Pharmaceutical Marijuana (MMJ) Sales by Region (2025-2030) & (Kiloton)
Table 38. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2024) & (Kiloton)
Table 42. Latin America Pharmaceutical Marijuana (MMJ) Sales by Country (2025-2030) & (Kiloton)
Table 43. Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2019-2024) & (Kiloton)
Table 47. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2025-2030) & (Kiloton)
Table 48. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Type (2019-2024)
Table 51. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Type (2025-2030)
Table 52. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2019-2024)
Table 53. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2025-2030)
Table 54. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2019-2024)
Table 57. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2025-2030)
Table 58. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Type (2019-2024)
Table 59. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Type (2025-2030)
Table 60. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Application (2019-2024)
Table 61. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Application (2025-2030)
Table 62. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2019-2024)
Table 63. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2025-2030)
Table 64. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2019-2024)
Table 67. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2025-2030)
Table 68. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Application (2019-2024)
Table 69. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Application (2025-2030)
Table 70. Canopy Growth Corporation Corporation Information
Table 71. Canopy Growth Corporation Description and Business Overview
Table 72. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 73. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product
Table 74. Canopy Growth Corporation Recent Developments/Updates
Table 75. GW Pharmaceuticals, plc Corporation Information
Table 76. GW Pharmaceuticals, plc Description and Business Overview
Table 77. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 78. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product
Table 79. GW Pharmaceuticals, plc Recent Developments/Updates
Table 80. Aurora Cannabis, Inc. Corporation Information
Table 81. Aurora Cannabis, Inc. Description and Business Overview
Table 82. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 83. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 84. Aurora Cannabis, Inc. Recent Developments/Updates
Table 85. Aphria, Inc. Corporation Information
Table 86. Aphria, Inc. Description and Business Overview
Table 87. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 88. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 89. Aphria, Inc. Recent Developments/Updates
Table 90. MedReleaf Corporation Corporation Information
Table 91. MedReleaf Corporation Description and Business Overview
Table 92. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 93. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product
Table 94. MedReleaf Corporation Recent Developments/Updates
Table 95. Insys Therapeutics, Inc. Corporation Information
Table 96. Insys Therapeutics, Inc. Description and Business Overview
Table 97. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 98. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 99. Insys Therapeutics, Inc. Recent Developments/Updates
Table 100. CanniMed Therapeutics, Inc. Corporation Information
Table 101. CanniMed Therapeutics, Inc. Description and Business Overview
Table 102. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 103. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 104. CanniMed Therapeutics, Inc. Recent Developments/Updates
Table 105. Cara Therapeutics, Inc. Corporation Information
Table 106. Cara Therapeutics, Inc. Description and Business Overview
Table 107. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 108. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 109. Cara Therapeutics, Inc. Recent Developments/Updates
Table 110. United Cannabis Corporation Corporation Information
Table 111. United Cannabis Corporation Description and Business Overview
Table 112. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 113. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product
Table 114. United Cannabis Corporation Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pharmaceutical Marijuana (MMJ) Distributors List
Table 118. Pharmaceutical Marijuana (MMJ) Customers List
Table 119. Pharmaceutical Marijuana (MMJ) Market Trends
Table 120. Pharmaceutical Marijuana (MMJ) Market Drivers
Table 121. Pharmaceutical Marijuana (MMJ) Market Challenges
Table 122. Pharmaceutical Marijuana (MMJ) Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pharmaceutical Marijuana (MMJ)
Figure 2. Global Pharmaceutical Marijuana (MMJ) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pharmaceutical Marijuana (MMJ) Market Share by Type in 2023 & 2030
Figure 4. THC-dominant Product Picture
Figure 5. CBD-dominant Product Picture
Figure 6. Balanced THC & CBD Product Picture
Figure 7. Global Pharmaceutical Marijuana (MMJ) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pharmaceutical Marijuana (MMJ) Market Share by Application in 2023 & 2030
Figure 9. Cancer
Figure 10. Arthritis
Figure 11. Migraine
Figure 12. Epilepsy
Figure 13. Others
Figure 14. Global Pharmaceutical Marijuana (MMJ) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pharmaceutical Marijuana (MMJ) Market Size (2019-2030) & (US$ Million)
Figure 16. Global Pharmaceutical Marijuana (MMJ) Sales (2019-2030) & (Kiloton)
Figure 17. Global Pharmaceutical Marijuana (MMJ) Average Price (US$/KG) & (2019-2030)
Figure 18. Pharmaceutical Marijuana (MMJ) Report Years Considered
Figure 19. Pharmaceutical Marijuana (MMJ) Sales Share by Manufacturers in 2023
Figure 20. Global Pharmaceutical Marijuana (MMJ) Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Pharmaceutical Marijuana (MMJ) Players: Market Share by Revenue in 2023
Figure 22. Pharmaceutical Marijuana (MMJ) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Pharmaceutical Marijuana (MMJ) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2019-2030)
Figure 25. North America Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2019-2030)
Figure 26. United States Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2019-2030)
Figure 29. Europe Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2019-2030)
Figure 30. Germany Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2019-2030)
Figure 37. China Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2019-2030)
Figure 47. Latin America Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Pharmaceutical Marijuana (MMJ) by Type (2019-2030)
Figure 57. Global Revenue Market Share of Pharmaceutical Marijuana (MMJ) by Type (2019-2030)
Figure 58. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Type (2019-2030)
Figure 59. Global Sales Market Share of Pharmaceutical Marijuana (MMJ) by Application (2019-2030)
Figure 60. Global Revenue Market Share of Pharmaceutical Marijuana (MMJ) by Application (2019-2030)
Figure 61. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Application (2019-2030)
Figure 62. Pharmaceutical Marijuana (MMJ) Value Chain
Figure 63. Pharmaceutical Marijuana (MMJ) Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
